Every SEC Form 3/4/5 on record for this filer (CIK 1838139) — 1 issuer, 34 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | EVP, Research & Investments | 2020-12-31 → 2026-06-25 | 31 | −$18M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RPRX | 2026-06-24 | Sell | 9,098 | $55.18 | $502,028 | 9,099 |
| RPRX | 2026-05-20 | Sell | 13,684 | $52.75 | $721,831 | 18,197 |
| RPRX | 2026-05-14 | Sell | 13,684 | $53.06 | $726,073 | 31,881 |
| RPRX | 2026-01-30 | Sell | 20,000 | $41.09 | $821,800 | — |
| RPRX | 2026-01-23 | Sell | 20,000 | $40.26 | $805,200 | 20,000 |
| RPRX | 2026-01-16 | Sell | 20,000 | $39.52 | $790,400 | 40,000 |
| RPRX | 2026-01-09 | Sell | 20,000 | $40.78 | $815,600 | 60,000 |
| RPRX | 2026-01-02 | Sell | 20,000 | $38.48 | $769,600 | 80,000 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.
